The total value of the Japanese market is 170 billion yen. The size of the prescription drug market is constant and the growth is slow. In recent years, the OTC market has grown rapidly, increasing by 25% in 2007 compared to 2006.
The market of plant medicine in Japan is divided into crude medicine and Chinese medicine. In terms of regulation, they are divided into prescription drugs and OTC products, so their distribution channels are also significantly different. Prescription drugs are available in hospitals, while OTC drugs are available in drugstores, supermarkets and personal care stores.
In terms of the market, the size of prescription drugs is larger, about 130 billion yen in 2007, while that of OTC products is smaller, 40 billion yen in 2007. However, compared with 2006, the market size of OTC products is growing rapidly, reaching 25%.
Capacity of the market
Japanese Chinese medicine and Chinese medicine belong to the same root and origin. According to the statistics of the Institute of Social Research in Japan, the number of manufacturers of ordinary Chinese prescription products increased from 92 in 1996 to 111 in 1999, and the number of types also increased from 2,154 in 1996 to 2,812 in 1999. Chinese medicine has been widely used in the treatment of senile diseases and chronic diseases, and the number of doctors who recognize the efficacy of Chinese medicine has gradually increased. At present, 72% of the doctors are using Chinese medicine, and 70% of them have been using Chinese medicine for 10 years.
At present, 233 kinds of Chinese formulations have been listed in the price list of Japanese medical insurance. There are 149 kinds of Hanfang preparations, 903 varieties in total due to the different dosage forms of manufacturers. Among them, the drugs with output value **** and dosage **** are called special drugs. There are also 10 preparations of “seven soups, two powders and one pill” (small buplehu soup, Chaipu soup, Buzhong Yiqi soup, Jiawei Xiaoyao Powder, eight flavors Dihuang pill, small Qinglong soup, Liujunzi soup, Chaihugui, wheat Mengdong soup and Angelica Peony soup), the output value of ****.
At present, there are more than 30,000 Japanese researchers specializing in Han medicine research. At present, there are more than 200 Hanfang pharmaceutical factories in Japan, and the number of prescription Hanfang medicines is growing at a rate of 15 percent every year, with annual sales reaching 100 billion yen. The production of Chinese prescription medicine in Japan is mainly concentrated in Tsumura, Jongfong, Osugi, Imperial, Bencao and other pharmaceutical enterprises, accounting for more than 97% of the total output value of Chinese prescription medicine. The production of traditional Chinese medicine preparations in Japan is highly centralized, forming economies of scale, which can concentrate on research and development, improve the process and improve the quality.
Post time: Dec-09-2022
.png)
